Kreft K - Search Results

1

Establishing a Cardiac ICU Recovery Clinic: Characterizing a Model for Continuity of Cardiac Critical Care.

Whiteside HL, Hillerson D, Buescher V, Kreft K, Mayer KP, Montgomery-Yates A, Gupta VA. Whiteside HL, et al. Among authors: kreft k. Crit Pathw Cardiol. 2022 Sep 1;21(3):135-140. doi: 10.1097/HPC.0000000000000294. Epub 2022 Aug 18. Crit Pathw Cardiol. 2022. PMID: 35994722

2

Impact of a transitions of care pilot service established by pharmacy residents within an academic medical center.

O'Reilly EA, Kuszmaul AK, Carter AM, Kreft KN, Spencer CA. O'Reilly EA, et al. Among authors: kreft kn. J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):87-92.e2. doi: 10.1016/j.japh.2019.09.018. Epub 2019 Nov 14. J Am Pharm Assoc (2003). 2020. PMID: 31735651

3

Safety and efficacy of dolutegravir in hemodialysis.

Kreft KN, Spencer CA, Raghuram A. Kreft KN, et al. Int J STD AIDS. 2019 May;30(6):530-535. doi: 10.1177/0956462418816785. Epub 2019 Feb 4. Int J STD AIDS. 2019. PMID: 31074360

4

Modelling Disease progression of Multiple Sclerosis in a South Wales Cohort.

Uzochukwu EC, Harding KE, Hrastelj J, Kreft KL, Holmans P, Robertson NP, Tallantyre EC, Lawton M. Uzochukwu EC, et al. Among authors: kreft kl. Neuroepidemiology. 2024 Feb 20. doi: 10.1159/000536427. Online ahead of print. Neuroepidemiology. 2024. PMID: 38377969

5

Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.

Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP, Zelek WM, Tallantyre EC. Kodosaki E, et al. Among authors: kreft kl. J Neuroinflammation. 2024 Feb 17;21(1):52. doi: 10.1186/s12974-024-03036-4. J Neuroinflammation. 2024. PMID: 38368354 Free PMC article.

6

Prodromal multiple sclerosis: considerations and future utility.

Harding KE, Kreft KL, Ben-Shlomo Y, Robertson NP. Harding KE, et al. Among authors: kreft kl. J Neurol. 2024 Apr;271(4):2129-2140. doi: 10.1007/s00415-023-12173-4. Epub 2024 Feb 11. J Neurol. 2024. PMID: 38341810 Free PMC article. Review.

7

Correlating mechanical and rheological filament properties to processability and quality of 3D printed tablets using multiple linear regression.

Kreft K, Lavrič Z, Gradišar Centa U, Mihelčič M, Slemenik Perše L, Dreu R. Kreft K, et al. Int J Pharm. 2024 Feb 15;651:123719. doi: 10.1016/j.ijpharm.2023.123719. Epub 2023 Dec 16. Int J Pharm. 2024. PMID: 38110015 Free article.

8

Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.

Kreft KL, Uzochukwu E, Loveless S, Willis M, Wynford-Thomas R, Harding KE, Holmans P, Lawton M, Tallantyre EC, Robertson NP. Kreft KL, et al. Ann Neurol. 2024 Mar;95(3):459-470. doi: 10.1002/ana.26831. Epub 2023 Dec 9. Ann Neurol. 2024. PMID: 37974536

9

Influence of fused deposition modelling printing parameters on tablet disintegration times: a design of experiments study.

Kreft K, Stanić T, Perhavec P, Dreu R, Lavrič Z. Kreft K, et al. Acta Pharm. 2023 Sep 14;73(3):405-422. doi: 10.2478/acph-2023-0026. Print 2023 Sep 1. Acta Pharm. 2023. PMID: 37708955 Free article.

10

Locus for severity implicates CNS resilience in progression of multiple sclerosis.

International Multiple Sclerosis Genetics Consortium; MultipleMS Consortium. International Multiple Sclerosis Genetics Consortium, et al. Nature. 2023 Jul;619(7969):323-331. doi: 10.1038/s41586-023-06250-x. Epub 2023 Jun 28. Nature. 2023. PMID: 37380766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page